The neuroscience-driven approach also promises a more efficient drug development process. By running small proof-of-mechanism trials to ensure that an experimental drug targets the intended ...

Cynaptec is a newly created private Delaware corporation which will own and develop the Company's novel drug development candidate Conjugated Psilocin TM. Lobe Sciences previously announced its ...

The agency will instead promote the use of more effective, human-relevant methods that are expected to improve drug safety and accelerate the evaluation process, while reducing animal experimentation, ...

Samsung Electronics has reportedly kicked off the development of its next-generation 1nm process node, something the South Korean giant calls the "dream semiconductor process". In a new report ...

designed to modernize the drug development process and empower free market competition.” The appropriators also noted that “[s]ignificant delays may sow confusion among drug sponsors and ...

New drug frameworks have been developed to selectively target CYP3A4, a key cytochrome P450 protein responsible for metabolizing many drugs, including paclitaxel and nirmatrelvir.

Inc.). “The collaboration underscores the transformative potential of our in silico technologies in drug development and exemplifies how digital tools can bridge the gap between preclinical ...